Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Genomics (NASDAQ:TXG – Get Free Report) had its price objective reduced by equities researchers at Stifel Nicolaus from ...

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda ...

A major new investment into genomics research highlights the importance of genomics to New Zealand's future wellbeing and ...

ProPhase Labs (PRPH) is focused on immediate cash generation through two key initiatives: strategic alternatives including a potential sale of ...

Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.